“We’re fortunate to work in an industry that benefits from decades of investment and is now brimming with possibility to improve human health. But if we don’t do our part to maintain a healthy ecosystem, we’ll find ourselves on increasingly rocky, slippery, dead-end trails”
–Steve Potts, founding CEO, Anticipate BioscienceContinue reading
New pacemakers offer 40% more battery life, extend Medtronic legacy of pacing leadershipContinue reading
TGen scientists test new NGS technologies for utility in large-scale pandemic responses
NuvOx Receives SPAN Grant to Conduct Late-stage Preclinical Studies of Putative Neuroprotectants Combined with ReperfusionContinue reading
NeoLight has signed a binding agreement to acquire key assets of interVIEW Medical Systems ROP (retinopathy-of-prematurity) risk management education course and ROP risk management clinical exam, collectively called the ROP Certification Program.Continue reading
TUCSON, Ariz., April 25, 2023 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today provided an update on partnering discussions for its drug discovery business unit.Continue reading
ASU joins international team to study disease evolution
Stockdale Capital Partners, a Los Angeles-based, vertically-integrated real estate investment firm, is committing over $20 million on a major renovation plan to finish converting Ilume Innovation Center in Scottsdale, Arizona to be a fully lab-enabled life science facility. The renovation will also include several move-in-ready wet lab suites, and upgraded tenant amenities including a fitness center, 110-person capacity auditorium, meeting space, tenant lounge, and 1.5-acre rooftop garden.
Continue reading
TUCSON, Ariz., April 18, 2023 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced the achievement of three significant drug discovery business milestones in the first quarter of 2023.Continue reading
Strategikon Pharma offers an end-to-end cloud-based platform to more efficiently budget, source and manage complex clinical trials